Description
Trifluoroacetic Acid Market Research Report Forecast 2030
Market Overview
The worldwide trifluoroacetic acid market share is probably going to accomplish an approximate CAGR of 5.27% during the continuous estimated time frame to outperform USD 467.6 million toward the finish of 2030. Trifluoroacetic acid (TFA) is an area of strength for an acid generally utilized in organic science. TFA is a significant part of the amalgamation of drugs, agrochemicals, and execution items.
Moreover, the worldwide trifluoroacetic acid market is developing interest from key end-clients like drugs and the agrochemical business. Wherein, poisonous nature and ecological effects raise worry over the utilization of trifluoroacetic acid and increment upkeep and removal expenses could be controlling variables for the trifluoroacetic acid market.
The worldwide interest in trifluoracetic acid is principally determined by the development of the rural business. A large portion of the TFA delivered is consumed by the pesticides business. TFA is a typical part of farming synthetic substances like insect poisons, herbicides, and fungicides. Around 8.5% of the pesticide passages in the pesticides manual contain a CF3 bunch got by TFA
Market Segmentation
The global trifluoroacetic acid market is segmented based on Type and Application.
Based on Type the market is divided into Above 99.5% trifluoroacetic acid and Others. The Application segment is further categorized into medical intermediates, Pesticide Intermediates, and Others.
Regional Analysis
Asia-Pacific dominated the worldwide market with a worth portion of 38.15 % in 2021 and is projected to register the most noteworthy CAGR of 5.8% to arrive at USD 116.42 million toward the finish of 2030. The market development in Asia-Pacific is driven by different variables, including rising industrialization and urbanization, expanded unfamiliar ventures, government sponsorships, and rising interest from South Asian nations like India, Thailand, and Indonesia. Europe held the second-biggest market portion of 29.81% in 2020 because of the development of significant end-use enterprises in the region.
Europe held the second-biggest market portion of 29.81% in 2020 because of the development of significant end-use businesses in the region because of its broad utilization of drugs, agrochemicals, and execution items. In 2020, The development of markets in Latin America and the Middle East, and Africa is probably going to be driven by expansion. The climb in the developing people prompts a rising number of illnesses and the need for clinical offices, which support the development of worldwide drug enterprises.
The North American market represented the third-biggest offer in 2020 and is projected to record a CAGR of 3.0% during the survey time frame. Also, the rising interest in corn, grains, and other corn items is energizing the development of the horticultural business in the US and, accordingly, the trifluoroacetic acid market.
Major Players
The major players operating in the global market are Halocarbon LLC, SINOCHEM GROUP CO., LTD., Solvay, SRF Limited, Anhui Jin’ao Chemical Co., Ltd., and Midas Pharma GmbH. The market is highly consolidated, with Solvay, SRF Limited, NANTONG BAOKAI PHARMACEUTICAL CO. Ltd, and SINOCHEM holding.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 14
1.1.1 GLOBAL TRIFLUOROACETIC ACID MARKET, BY TYPE 16
1.1.2 GLOBAL TRIFLUOROACETIC ACID MARKET, BY APPLICATION 17
1.1.3 GLOBAL TRIFLUOROACETIC ACID MARKET, BY REGION 18
2 MARKET INTRODUCTION 19
2.1 DEFINITION 19
2.2 SCOPE OF THE STUDY 19
2.3 MARKET STRUCTURE 19
3 RESEARCH METHODOLOGY 20
3.1 RESEARCH PROCESS 20
3.2 PRIMARY RESEARCH 21
3.3 SECONDARY RESEARCH 22
3.4 MARKET SIZE ESTIMATION 22
3.5 FORECAST MODEL 24
3.6 LIST OF ASSUMPTIONS 24
4 MARKET DYNAMICS 25
4.1 INTRODUCTION 25
4.2 DRIVERS 26
4.2.1 HIGH DEMAND FROM THE PHARMACEUTICAL INDUSTRY 26
4.2.2 GROWTH OF THE AGRICULTURE INDUSTRY 27
4.2.3 DRIVERS IMPACT ANALYSIS 28
4.3 RESTRAINTS 28
4.3.1 TOXIC NATURE AND ENVIRONMENTAL CONCERNS 28
4.3.2 RESTRAINTS IMPACT ANALYSIS 29
4.4 OPPORTUNITIES 29
4.4.1 POSITIVE OUTLOOK OF THE PHARMACEUTICAL INDUSTRY IN SOUTH ASIA 29
4.5 CHALLENGES 30
4.5.1 AVAILABILITY OF SUBSTITUTES 30
5 MARKET FACTOR ANALYSIS 31
5.1 SUPPLY CHAIN ANALYSIS 31
5.1.1 RAW MATERIALS SUPPLIERS 32
5.1.2 TRIFLUOROACETIC ACID MANUFACTURERS 32
5.1.3 DISTRIBUTION CHANNEL 32
5.1.4 APPLICATIONS 32
5.2 PORTER’S FIVE FORCES MODEL 33
5.2.1 THREAT OF NEW ENTRANTS 33
5.2.2 BARGAINING POWER OF SUPPLIERS 33
5.2.3 THREAT OF SUBSTITUTES 34
5.2.4 BARGAINING POWER OF BUYERS 34
5.2.5 INTENSITY OF COMPETITIVE RIVALRY 34
5.3 PRICING ANALYSIS, BY REGION 34
5.4 IMPACT OF COVID-19 ON THE GLOBAL TRIFLUOROACETIC ACID MARKET 34
5.4.1 PRODUCTION SCENARIO 34
5.4.2 IMPACT ON SUPPLY CHAIN 35
5.4.2.1 RAW MATERIAL SUPPLY 35
5.4.2.2 SUPPLY/ DISTRIBUTION 35
5.4.2.3 IMPACT ON END USE INDUSTRY DEMAND 35
5.4.3 MAJOR GOVERNMENT POLICIES TO COUNTER THE IMPACT OF COVID-19 36
6 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY TYPE 39
6.1 OVERVIEW 39
6.1.1 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
6.1.2 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
6.2 ABOVE 99.5% TRIFLUOROACETIC ACID 41
6.2.1 ABOVE 99.5% TRIFLUOROACETIC ACID: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 41
6.3 OTHERS 42
6.3.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 42
7 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY APPLICATION 43
7.1 OVERVIEW 43
7.1.1 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 44
7.1.2 TRIFLUOROACETIC ACID (TFA): MARKET ESTIMATES & FORECAST BY APPLICATION, 2019-2030 45
7.2 MEDICAL INTERMEDIATES 45
7.2.1 MEDICAL INTERMEDIATES: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 45
7.3 PESTICIDE INTERMEDIATES 46
7.3.1 PESTICIDE INTERMEDIATES: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 46
7.4 OTHERS 47
7.4.1 OTHERS: MARKET ESTIMATES & FORECAST BY REGION, 2019-2030 47
8 GLOBAL TRIFLUOROACETIC ACID (TFA) MARKET, BY REGION 49
8.1 OVERVIEW 49
8.2 NORTH AMERICA 52
8.2.1 US 54
8.2.2 CANADA 55
8.3 EUROPE 57
8.3.1 GERMANY 59
8.3.2 UK 61
8.3.3 FRANCE 62
8.3.4 SPAIN 63
8.3.5 ITALY 65
8.3.6 RUSSIA 66
8.3.7 REST OF EUROPE 67
8.4 ASIA-PACIFIC 69
8.4.1 CHINA 71
8.4.2 JAPAN 73
8.4.3 INDIA 74
8.4.4 SOUTH KOREA 75
8.4.5 AUSTRALIA & NEW ZEALAND 77
8.4.6 REST OF ASIA-PACIFIC 78
8.5 LATIN AMERICA 80
8.5.1 BRAZIL 82
8.5.2 MEXICO 83
8.5.3 ARGENTINA 84
8.5.4 REST OF LATIN AMERICA 86
8.6 THE MIDDLE EAST & AFRICA 88
8.6.1 GCC 90
8.6.2 ISRAEL 92
8.6.3 SOUTH AFRICA 93
8.6.4 REST OF THE MIDDLE EAST & AFRICA 94
9 COMPETITIVE LANDSCAPE 96
9.1 INTRODUCTION 96
9.2 MARKET STRATEGY ANALYSIS 96
9.3 COMPETITIVE BENCHMARKING 97
10 COMPANY PROFILES 98
10.1 SOLVAY 98
10.1.1 COMPANY OVERVIEW 98
10.1.2 FINANCIAL OVERVIEW 98
10.1.3 PRODUCTS OFFERED 99
10.1.4 KEY DEVELOPMENTS 99
10.1.5 SWOT ANALYSIS 99
10.1.6 KEY STRATEGIES 100
10.2 SRF LIMITED 101
10.2.1 COMPANY OVERVIEW 101
10.2.2 FINANCIAL OVERVIEW 101
10.2.3 PRODUCTS OFFERED 102
10.2.4 KEY DEVELOPMENTS 102
10.2.5 SWOT ANALYSIS 102
10.2.6 KEY STRATEGIES 102
10.3 HALOCARBON LLC 103
10.3.1 COMPANY OVERVIEW 103
10.3.2 FINANCIAL OVERVIEW 103
10.3.3 PRODUCTS OFFERED 103
10.3.4 KEY DEVELOPMENT 103
10.3.5 SWOT ANALYSIS 104
10.3.6 KEY STRATEGIES 104
10.4 SINOCHEM GROUP CO., LTD 105
10.4.1 COMPANY OVERVIEW 105
10.4.2 FINANCIAL OVERVIEW 105
10.4.3 PRODUCTS OFFERED 106
10.4.4 KEY DEVELOPMENTS 106
10.4.5 SWOT ANALYSIS 106
10.4.6 KEY STRATEGIES 106
10.5 ANHUI JIN’AO CHEMICAL CO., LTD 107
10.5.1 COMPANY OVERVIEW 107
10.5.2 FINANCIAL OVERVIEW 107
10.5.3 PRODUCTS OFFERED 107
10.5.4 KEY DEVELOPMENTS 107
10.5.5 SWOT ANALYSIS 108
10.5.6 KEY STRATEGIES 108
10.6 NANTONG BAOKAI PHARMACEUTICAL CO., LTD 109
10.6.1 COMPANY OVERVIEW 109
10.6.2 FINANCIAL OVERVIEW 109
10.6.3 PRODUCTS OFFERED 109
10.6.4 KEY DEVELOPMENTS 109
10.6.5 SWOT ANALYSIS 110
10.6.6 KEY STRATEGIES 110
10.7 MIDAS PHARMA GMBH 111
10.7.1 COMPANY OVERVIEW 111
10.7.2 FINANCIAL OVERVIEW 111
10.7.3 PRODUCTS OFFERED 111
10.7.4 KEY DEVELOPMENTS 111
10.7.5 SWOT ANALYSIS 112
10.7.6 KEY STRATEGIES 112
11 APPENDIX 113
11.1 REFERENCES 113
11.2 RELATED REPORTS 113
Reviews
There are no reviews yet.